Cargando…

UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment

Taohong Siwu decoction (THSWD) is a classic traditional Chinese medicine (TCM) prescription that is widely used in the clinical treatment of gynecological and cerebrovascular diseases. Here we used a method that coupled ultra-performance liquid chromatography to quadrupole time-of-flight mass spectr...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xianchun, Pan, Lingyu, Bao, Qiuyu, Peng, Daiyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993183/
https://www.ncbi.nlm.nih.gov/pubmed/32038266
http://dx.doi.org/10.3389/fphar.2019.01625
_version_ 1783492976800956416
author Duan, Xianchun
Pan, Lingyu
Bao, Qiuyu
Peng, Daiyin
author_facet Duan, Xianchun
Pan, Lingyu
Bao, Qiuyu
Peng, Daiyin
author_sort Duan, Xianchun
collection PubMed
description Taohong Siwu decoction (THSWD) is a classic traditional Chinese medicine (TCM) prescription that is widely used in the clinical treatment of gynecological and cerebrovascular diseases. Here we used a method that coupled ultra-performance liquid chromatography to quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) in which both positive and negative ion modes were established to investigate the major constituents in THSWD. A Waters ACQUITY UPLC BEH C18 column (2.1 mm×100 mm, 1.7 μm) was used to separate the aqueous extract of THSWD. The mobile phase consisted of 0.1% aqueous formic acid (A) and acetonitrile (B). Ninety-five components were identified in two different ion modes, including aromatic acids, flavones, polysaccharides, volatile oils monoterpene glycosides, aromatic cyanogenic glycosides, and others. Pathological changes in tumors and serum expression of interleukin-4 in a mouse model of breast cancer were detected after THSWD treatment. The results showed that THSWD had obvious therapeutic effects. This study establishes a material basis for the use of THSWD in the treatment of breast cancer.
format Online
Article
Text
id pubmed-6993183
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69931832020-02-07 UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment Duan, Xianchun Pan, Lingyu Bao, Qiuyu Peng, Daiyin Front Pharmacol Pharmacology Taohong Siwu decoction (THSWD) is a classic traditional Chinese medicine (TCM) prescription that is widely used in the clinical treatment of gynecological and cerebrovascular diseases. Here we used a method that coupled ultra-performance liquid chromatography to quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) in which both positive and negative ion modes were established to investigate the major constituents in THSWD. A Waters ACQUITY UPLC BEH C18 column (2.1 mm×100 mm, 1.7 μm) was used to separate the aqueous extract of THSWD. The mobile phase consisted of 0.1% aqueous formic acid (A) and acetonitrile (B). Ninety-five components were identified in two different ion modes, including aromatic acids, flavones, polysaccharides, volatile oils monoterpene glycosides, aromatic cyanogenic glycosides, and others. Pathological changes in tumors and serum expression of interleukin-4 in a mouse model of breast cancer were detected after THSWD treatment. The results showed that THSWD had obvious therapeutic effects. This study establishes a material basis for the use of THSWD in the treatment of breast cancer. Frontiers Media S.A. 2020-01-24 /pmc/articles/PMC6993183/ /pubmed/32038266 http://dx.doi.org/10.3389/fphar.2019.01625 Text en Copyright © 2020 Duan, Pan, Bao and Peng http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Duan, Xianchun
Pan, Lingyu
Bao, Qiuyu
Peng, Daiyin
UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment
title UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment
title_full UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment
title_fullStr UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment
title_full_unstemmed UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment
title_short UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment
title_sort uplc-q-tof-ms study of the mechanism of thswd for breast cancer treatment
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993183/
https://www.ncbi.nlm.nih.gov/pubmed/32038266
http://dx.doi.org/10.3389/fphar.2019.01625
work_keys_str_mv AT duanxianchun uplcqtofmsstudyofthemechanismofthswdforbreastcancertreatment
AT panlingyu uplcqtofmsstudyofthemechanismofthswdforbreastcancertreatment
AT baoqiuyu uplcqtofmsstudyofthemechanismofthswdforbreastcancertreatment
AT pengdaiyin uplcqtofmsstudyofthemechanismofthswdforbreastcancertreatment